Pratiksha Dhote

Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:53:44 -

Biosimilars are eating Humira's lunch — and that's a good thing
Humira's patent expired in 2016, but AbbVie fought off biosimilars for years. Now, the floodgates have opened. The US tumor necrosis factor alpha inhibitors market forecast shows that biosimilars will capture over 50% of the market by 2030, driving prices down. In 2023, the first biosimilar of Humira (Amjevita) launched at a 50% discount. That's huge for patients with high...

0 Comments 0 Shares 431 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:47:38 -

Biosimilars are eating Humira's lunch — and that's good for patients
Humira (adalimumab) was a $20 billion drug — until biosimilars arrived in 2023. Now, prices have dropped by 50‑80%, making TNF inhibitors accessible to millions more patients. The TNF alpha inhibitors market forecast predicts that biosimilars will capture over 70% of the market by 2035. Why the shift? Because payers are forcing substitution, and patients are willing to...

0 Comments 0 Shares 443 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:47:15 -

Liver cancer ablation: the largest and most successful application
Liver cancer is often diagnosed in patients with cirrhosis, who are poor surgical candidates. That's where ablation shines. The US tumor ablation market forecast shows that liver cancer is the largest application, driven by the high incidence of hepatocellular carcinoma (HCC) and the rise of surveillance programs for cirrhotic patients. Ablation offers 90% local tumour control for...

0 Comments 0 Shares 411 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:46:51 -

Liver cancer ablation: the $1B market that's saving lives
Liver cancer is the third leading cause of cancer death worldwide. For small tumours (<3cm), ablation is as effective as surgery, with fewer complications. The tumor ablation market forecast shows that liver cancer is the largest application, accounting for 37% of the market. Why the dominance? Because many liver cancer patients have cirrhosis and can't tolerate surgery —...

0 Comments 0 Shares 409 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:46:29 -

Doxycycline vs. ciprofloxacin: which antibiotic for tularemia?
Both work. Doxycycline is bacteriostatic (stops growth), while ciprofloxacin is bactericidal (kills bacteria). The US tularemia market forecast shows that antibiotic therapy holds the largest treatment share, because early treatment is highly effective. But there's a debate: some experts prefer ciprofloxacin for pneumonic tularemia because it achieves higher lung concentrations....

0 Comments 0 Shares 433 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:46:08 -

Antibiotics work, but tularemia can be tricky: why doxycycline is the go‑to
Streptomycin used to be the gold standard, but it's hard to find. Now, doxycycline and ciprofloxacin are first‑line. The tularemia market forecast shows that antibiotic therapy holds the largest treatment share, because it's highly effective if started early. But tularemia can relapse if treatment is too short — that's why 10‑14 days of doxycycline is recommended. What's the...

0 Comments 0 Shares 424 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:39:04 -

Adults vs. the elderly: who's using online doctor consultations most?
Adults (20‑65) are the largest demographic — they have busy lives, and they're comfortable with technology. But the elderly (65+) are the fastest‑growing segment. The online doctor consultation market forecast shows that the elderly segment is growing at over 15% CAGR, driven by the need to manage chronic diseases (diabetes, heart failure) without traveling to clinics. What's...

0 Comments 0 Shares 414 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:38:45 -

Home care vs. hospitals: where are nasal sprays used most?
Home care settings are the largest end‑user segment — patients buy OTC sprays at pharmacies and use them at home. But hospitals are the fastest‑growing segment. The nasal spray market forecast shows that hospitals are growing at over 8% CAGR, driven by the use of prescription sprays for post‑surgical care, pain management (fentanyl nasal spray), and even resuscitation...

0 Comments 0 Shares 388 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:38:22 -

Hospitals vs. home care: where is nanotechnology making the biggest impact?
Hospitals are the largest end‑user segment — they have the labs, the specialists, and the regulatory approval to use advanced nano devices. But home care is the fastest‑growing. The nano healthcare technology market forecast shows that home care is growing at over 11% CAGR, driven by the shift to remote patient monitoring and aging in place. What's happening at home? Patients...

0 Comments 0 Shares 431 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:29:35 -

Insulin resistance: the hidden driver of metabolic syndrome (and how to spot it early)
You can have perfect blood sugar on a fasting test and still be deeply insulin resistant. How? Because your pancreas is working overtime, pumping out extra insulin to keep glucose normal. But eventually, it tires out, and prediabetes/diabetes appears. The metabolic syndrome market analysis reveals that insulin resistance is the fastest‑growing risk factor segment, because clinicians...

0 Comments 0 Shares 451 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:28:11 -

Medical‑grade silicone vs. latex: which cup material is right for you?
Medical‑grade silicone is the gold standard — it's soft, flexible, and hypoallergenic. Latex is natural rubber — it's biodegradable but can cause allergies. The menstrual cup market forecast shows that silicone holds 68% market share, but latex is the fastest‑growing. Why the shift? Because some women want a plastic‑free option, and latex cups are compostable. What's the...

0 Comments 0 Shares 426 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Sağlıklı Yaşam
2026-04-16 09:27:49 -

Oncology second opinions: the dominant and most urgent segment
Cancer treatment is complex and often irreversible. Getting it wrong can be fatal. That's why oncology is the largest application in the second opinion market. The medical second opinion market forecast shows that the oncology segment will grow from $2.5 billion to over $10 billion by 2035. Why? Because new therapies (immunotherapy, targeted drugs) require precise biomarker testing,...

0 Comments 0 Shares 401 Views 0 Reviews

Please log in to like, share and comment!